Triple

T2126505
Position Surface form Disambiguated ID Type / Status
Subject Medtronic plc E46436 entity
Predicate segment P889 FINISHED
Object Minimally Invasive Therapies Group E46438 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Minimally Invasive Therapies Group | Statement: [Medtronic plc, segment, Minimally Invasive Therapies Group]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Minimally Invasive Therapies Group
Context triple: [Medtronic plc, segment, Minimally Invasive Therapies Group]
  • A. Minimally Invasive Therapies Group chosen
    Minimally Invasive Therapies Group is a Medtronic business unit focused on developing and providing technologies and solutions for minimally invasive surgical and interventional procedures.
  • B. Restorative Therapies Group
    Restorative Therapies Group is a Medtronic business segment focused on medical technologies for conditions affecting the spine, brain, nerves, and musculoskeletal system.
  • C. Cardiac and Vascular Group
    Cardiac and Vascular Group is a Medtronic business unit focused on developing medical technologies and therapies for heart and blood vessel diseases.
  • D. Center for Clinical Standards and Quality
    The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
  • E. Committee for Advanced Therapies
    The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88a1626548190ae59a5028c3baa8e completed March 4, 2026, 7:37 p.m.
NER Named-entity recognition batch_69abbb59182081908470f9be97e272c8 completed March 7, 2026, 5:44 a.m.
NED1 Entity disambiguation (via context triple) batch_69ae51a0e8ac8190992588bf2bf496ab completed March 9, 2026, 4:50 a.m.
Created at: March 4, 2026, 7:44 p.m.